{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:25:33Z","timestamp":1778599533084,"version":"3.51.4"},"reference-count":38,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T00:00:00Z","timestamp":1287619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Liuweidihuang Wan (LW), initially a well-known formula for curing \u201cwu chi wu ruan\u201d, is commonly used nowadays for clinical treatment of Postmenopausal Osteoporosis (PO), but the identity of the effective substance(s) remains unclear. The present study was designed to evaluate the effects of morroniside and loganin isolated from LW on the proliferation, differentiation and apoptosis of MC3T3-E1 cells, as well as the possible mechanism of action. Morroniside and loganin had no effects on the proliferation of MC3T3-E1 cells, but both susbtances could improve the activity of alkaline phosphatase (ALP), and increase the contents of collagen type I and osteocalcin. Simultaneously, the mRNA expression of caspase-3, capase-9, RANKL was down-regulated and that of bcl-2 was up-regulated, which partially explains the anti-osteoporosis mechanism in MC3T3-E1 cells. In conclusion, morroniside and loganin may directly promote the differentiation and inhibit the apoptosis of MC3T3-E1 cells, and accordingly indirectly reduce bone resorption, which makes them promising natural drugs leads for treating PO in the near future.<\/jats:p>","DOI":"10.3390\/molecules15107403","type":"journal-article","created":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T12:35:22Z","timestamp":1287664522000},"page":"7403-7414","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The Pharmacological Effects of Morroniside and Loganin Isolated from Liuweidihuang Wan, on MC3T3-E1 Cells"],"prefix":"10.3390","volume":"15","author":[{"given":"Manyu","family":"Li","sequence":"first","affiliation":[{"name":"National TCM Key Lab of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"National TCM Key Lab of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"National TCM Key Lab of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[{"name":"National TCM Key Lab of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[{"name":"National TCM Key Lab of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijun","family":"Wang","sequence":"additional","affiliation":[{"name":"National TCM Key Lab of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2010,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","article-title":"Epidemiology, etiology, and diagnosis of osteoporosis","volume":"194","author":"Lane","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis","volume":"367","author":"Sambrook","year":"2006","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","article-title":"Osteoporosis: a still increasing prevalence","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporosis Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.1996.00440120051005","article-title":"Osteoporosis. Frequency, consequences, and risk factors","volume":"156","author":"Ross","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.rdc.2006.08.003","article-title":"Epidemiology of osteoporosis","volume":"32","author":"Dennison","year":"2006","journal-title":"Rheum. Dis. Clin. N. Amer."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Invest."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(80)92592-1","article-title":"Prevention of spinal osteoporosis in oophorectomised women","volume":"2","author":"Lindsay","year":"1980","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jep.2006.01.012","article-title":"Herbal formulation, Yukmi-jihang-tang-Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression","volume":"106","author":"Jin","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"ref_11","first-page":"277","article-title":"Isolation and identification of constituents absorbed into blood after oral administration of Liuwei Dihuang Wan","volume":"15","author":"Wang","year":"2007","journal-title":"Chin. J. Nat. Med."},{"key":"ref_12","first-page":"219","article-title":"Studies on serum pharmacochemistry of Liuweidihuang Wan","volume":"2","author":"Wang","year":"2004","journal-title":"Chin. J. Nat. Med."},{"key":"ref_13","first-page":"33","article-title":"The protective effect of LW constituents absorbed into blood on the rat model of shen deficiency induced by hydrocortisone","volume":"14","author":"Wang","year":"2008","journal-title":"China J. Exp. Trad. Med. Formulae"},{"key":"ref_14","first-page":"79","article-title":"The interfere effects of LW on the bone density in PO patients","volume":"20","author":"Guan","year":"2009","journal-title":"Hainan Med."},{"key":"ref_15","first-page":"1","article-title":"The effects of LW on the biomechanics characteristics and the contents of Ca, P in osteoporotic rat model","volume":"18","author":"Han","year":"2002","journal-title":"Pharmacol. Clin. Chinese Mater. Med."},{"key":"ref_16","first-page":"5","article-title":"The effects of aqueous extract of Fructus Corni on the bone morphology in mice model of osteoporosis","volume":"15","author":"Chen","year":"2003","journal-title":"Tianjin Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.289.5484.1501","article-title":"The osteoblast: a sophisticated fibroblast under central surveillance","volume":"289","author":"Ducy","year":"2000","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/scdb.2000.0188","article-title":"Role of Cbfa1 in osteoblast differentiation and function","volume":"11","author":"Karsenty","year":"2000","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_19","first-page":"133","article-title":"Apoptosis: the biochemistry and molecular biology of programmed cell death","volume":"14","author":"Schwartzman","year":"1993","journal-title":"Endocr. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/stem.170306","article-title":"Apoptosis","volume":"17","author":"Israels","year":"1999","journal-title":"Stem Cells"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/excr.2000.4836","article-title":"Serine\/threonine protein kinases and apoptosis","volume":"256","author":"Cross","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/excr.2000.4833","article-title":"The mitochondrion in cell death control: certainties and incognita","volume":"256","author":"Loeffler","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines, and bone remodeling.Emerging insights into the pathophysiology of osteoporosis","volume":"332","author":"Manolagas","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1359\/jbmr.1998.13.5.793","article-title":"Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines","volume":"13","author":"Jilka","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J. Clin. Invest."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"J. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0167-4889(03)00100-9","article-title":"Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells","volume":"1642","author":"Chua","year":"2003","journal-title":"Biochem. Biophys. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1359\/JBMR.0301242","article-title":"Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k","volume":"19","author":"Liu","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.13.3.239","article-title":"IAP, family proteins \u2013 suppressors of apoptosis","volume":"13","author":"Deveraux","year":"1999","journal-title":"Genes Dev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1074\/jbc.M207197200","article-title":"Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac\/DIABLO","volume":"278","author":"Hu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/bbrc.1999.0252","article-title":"A new member of tumor necrosis factor ligand family, ODF\/OPGL\/TRANCE\/RANKL, regulates osteoclast differentiation and function","volume":"256","author":"Takahashi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0174-173X(87)80011-0","article-title":"Polar-apolar characteristics and fibrillogenesis of glycosylated collagen","volume":"7","author":"Amudeswari","year":"1987","journal-title":"Coll. Relat. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9343(99)00420-9","article-title":"Apoptosis and osteoporosis","volume":"108","author":"Weinstein","year":"2000","journal-title":"Amer. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1042\/bj3101045","article-title":"Biochemical changes in the collagenous matrix of osteoporotic avian bone","volume":"310","author":"Knott","year":"1995","journal-title":"Biochem. J."},{"key":"ref_36","first-page":"883","article-title":"Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity","volume":"131","author":"Turner","year":"1992","journal-title":"Endocrinology"},{"key":"ref_37","first-page":"189","article-title":"Osteoprotegerin ligand is required for murine osteoclasto genesis","volume":"23","author":"Boyle","year":"1998","journal-title":"Bone"},{"key":"ref_38","unstructured":"Pharmacopoeia Commission (2005). Pharmacopoeia of the People\u2019s Republic of China, Chemical Industry Press."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/15\/10\/7403\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:03:39Z","timestamp":1760220219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/15\/10\/7403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,21]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10]]}},"alternative-id":["molecules15107403"],"URL":"https:\/\/doi.org\/10.3390\/molecules15107403","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,21]]}}}